Vaxcyte Appoints John Furey to Board of Directors

"I am delighted to join Vaxcyte's Board of Directors and be part of a team dedicated to using a cell-free technology platform to develop novel vaccines designed to address bacterial infections such as invasive pneumococcal disease," said Mr. Furey. "I look forward to contributing as we advance the Company's broadspectrum PCVs with the potential to expand coverage and improve upon the standard-of-care for both infants and adults." About Vaxcyte Forward-Looking Statements Janet Graesser, Senior Vice President ...